CN Patent

CN113024521B — 一种制备恩曲替尼的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2023-01-17 · 3y expired

What this patent protects

本发明提供了一种制备恩曲替尼的方法。本发明所述的方法，其反应步数少，提高了反应的总收率；并且路线成熟，反应条件温和，不需要进行极低温反应，后处理简便，有利于大量合成目标产物，纯度可达99.8％，且有利于实现该产品的工业化生产。

USPTO Abstract

本发明提供了一种制备恩曲替尼的方法。本发明所述的方法，其反应步数少，提高了反应的总收率；并且路线成熟，反应条件温和，不需要进行极低温反应，后处理简便，有利于大量合成目标产物，纯度可达99.8％，且有利于实现该产品的工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN113024521B
Jurisdiction
CN
Classification
—
Expires
2023-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.